Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
This uncontrolled, non-comparative, observational study was conducted in the University Hospital Institute Méditerranée Infection in Marseille, France, in March 2020. From observing and treating a cohort of 80 mild COVID-19 patients and concurrently evaluating the synergy between hydroxychloroquine (HCQ) and azithromycin (AZM) in vitro, researchers saw a rapid decline in nasopharyngeal viral load and a decrease in viral carriage duration.
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
French open-label non-randomized clinical trial in support of treating COVID-19 patients with HCQ
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
In vitro testing revealed synergistic effect of combined hydroxychloroquine (HCQ) and azithromycin (AZM) on SARS-CoV-2
Learn After
Methods: Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Results: Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Discussion: Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study